Review



predesigned atgl small interfering rna sirna  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Thermo Fisher predesigned atgl small interfering rna sirna
    Inhibition of <t>ATGL</t> enhances cell migration capacity in NPC cell lines. (A) Staining of lipid droplets with BODIPY (493/503) (green), nuclei with Hoechst (blue), and anti‐ATGL immunofluorescent staining in red. Scale bar = 50 μm. (B, C) Migration assay. Images were taken at two time points after creating a cell‐free zone. Cells were cultured in the presence of DMSO/atglistatin (left panel) or transfected with <t>siRNA</t> control/siRNA ATGL (right panel). Scale bar = 500 μm. (D, E) Gap closures. Images reported in A, B, and C are representative of n = 3 independent experiments. Data are presented in D and E as means ± SD; for D and E, n = 3/group. * P < 0.05,*** P < 0.001, and **** P < 0.0001 as determined by Student's t ‐test.
    Predesigned Atgl Small Interfering Rna Sirna, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/predesigned atgl small interfering rna sirna/product/Thermo Fisher
    Average 86 stars, based on 1 article reviews
    predesigned atgl small interfering rna sirna - by Bioz Stars, 2026-02
    86/100 stars

    Images

    1) Product Images from "Downregulation of adipose triglyceride lipase by EB viral‐encoded LMP2A links lipid accumulation to increased migration in nasopharyngeal carcinoma"

    Article Title: Downregulation of adipose triglyceride lipase by EB viral‐encoded LMP2A links lipid accumulation to increased migration in nasopharyngeal carcinoma

    Journal: Molecular Oncology

    doi: 10.1002/1878-0261.12824

    Inhibition of ATGL enhances cell migration capacity in NPC cell lines. (A) Staining of lipid droplets with BODIPY (493/503) (green), nuclei with Hoechst (blue), and anti‐ATGL immunofluorescent staining in red. Scale bar = 50 μm. (B, C) Migration assay. Images were taken at two time points after creating a cell‐free zone. Cells were cultured in the presence of DMSO/atglistatin (left panel) or transfected with siRNA control/siRNA ATGL (right panel). Scale bar = 500 μm. (D, E) Gap closures. Images reported in A, B, and C are representative of n = 3 independent experiments. Data are presented in D and E as means ± SD; for D and E, n = 3/group. * P < 0.05,*** P < 0.001, and **** P < 0.0001 as determined by Student's t ‐test.
    Figure Legend Snippet: Inhibition of ATGL enhances cell migration capacity in NPC cell lines. (A) Staining of lipid droplets with BODIPY (493/503) (green), nuclei with Hoechst (blue), and anti‐ATGL immunofluorescent staining in red. Scale bar = 50 μm. (B, C) Migration assay. Images were taken at two time points after creating a cell‐free zone. Cells were cultured in the presence of DMSO/atglistatin (left panel) or transfected with siRNA control/siRNA ATGL (right panel). Scale bar = 500 μm. (D, E) Gap closures. Images reported in A, B, and C are representative of n = 3 independent experiments. Data are presented in D and E as means ± SD; for D and E, n = 3/group. * P < 0.05,*** P < 0.001, and **** P < 0.0001 as determined by Student's t ‐test.

    Techniques Used: Inhibition, Migration, Staining, Cell Culture, Transfection



    Similar Products

    86
    Thermo Fisher predesigned atgl small interfering rna sirna
    Inhibition of <t>ATGL</t> enhances cell migration capacity in NPC cell lines. (A) Staining of lipid droplets with BODIPY (493/503) (green), nuclei with Hoechst (blue), and anti‐ATGL immunofluorescent staining in red. Scale bar = 50 μm. (B, C) Migration assay. Images were taken at two time points after creating a cell‐free zone. Cells were cultured in the presence of DMSO/atglistatin (left panel) or transfected with <t>siRNA</t> control/siRNA ATGL (right panel). Scale bar = 500 μm. (D, E) Gap closures. Images reported in A, B, and C are representative of n = 3 independent experiments. Data are presented in D and E as means ± SD; for D and E, n = 3/group. * P < 0.05,*** P < 0.001, and **** P < 0.0001 as determined by Student's t ‐test.
    Predesigned Atgl Small Interfering Rna Sirna, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/predesigned atgl small interfering rna sirna/product/Thermo Fisher
    Average 86 stars, based on 1 article reviews
    predesigned atgl small interfering rna sirna - by Bioz Stars, 2026-02
    86/100 stars
      Buy from Supplier

    Image Search Results


    Inhibition of ATGL enhances cell migration capacity in NPC cell lines. (A) Staining of lipid droplets with BODIPY (493/503) (green), nuclei with Hoechst (blue), and anti‐ATGL immunofluorescent staining in red. Scale bar = 50 μm. (B, C) Migration assay. Images were taken at two time points after creating a cell‐free zone. Cells were cultured in the presence of DMSO/atglistatin (left panel) or transfected with siRNA control/siRNA ATGL (right panel). Scale bar = 500 μm. (D, E) Gap closures. Images reported in A, B, and C are representative of n = 3 independent experiments. Data are presented in D and E as means ± SD; for D and E, n = 3/group. * P < 0.05,*** P < 0.001, and **** P < 0.0001 as determined by Student's t ‐test.

    Journal: Molecular Oncology

    Article Title: Downregulation of adipose triglyceride lipase by EB viral‐encoded LMP2A links lipid accumulation to increased migration in nasopharyngeal carcinoma

    doi: 10.1002/1878-0261.12824

    Figure Lengend Snippet: Inhibition of ATGL enhances cell migration capacity in NPC cell lines. (A) Staining of lipid droplets with BODIPY (493/503) (green), nuclei with Hoechst (blue), and anti‐ATGL immunofluorescent staining in red. Scale bar = 50 μm. (B, C) Migration assay. Images were taken at two time points after creating a cell‐free zone. Cells were cultured in the presence of DMSO/atglistatin (left panel) or transfected with siRNA control/siRNA ATGL (right panel). Scale bar = 500 μm. (D, E) Gap closures. Images reported in A, B, and C are representative of n = 3 independent experiments. Data are presented in D and E as means ± SD; for D and E, n = 3/group. * P < 0.05,*** P < 0.001, and **** P < 0.0001 as determined by Student's t ‐test.

    Article Snippet: Following the manufacturer's protocol, 60 pmol predesigned ATGL small interfering RNA (siRNA) (AM16708, ID#121867; Ambion, Austin, TX, USA) or siRNA control (AM4390844; Ambion) and 20 μL Lipofectamine RNAiMAX Reagent (13778; Invitrogen, Carlsbad, CA, USA) were diluted in 300 μL Opti‐MEM reduced serum medium, separately, to prepare an siRNA–lipid complex.

    Techniques: Inhibition, Migration, Staining, Cell Culture, Transfection